Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.
Date Value
September 30, 2024 72.91M
June 30, 2024 88.06M
March 31, 2024 102.33M
December 31, 2023 113.39M
September 30, 2023 124.89M
June 30, 2023 135.46M
March 31, 2023 85.69M
December 31, 2022 94.75M
September 30, 2022 97.74M
June 30, 2022 106.69M
March 31, 2022 106.16M
December 31, 2021 119.20M
September 30, 2021 133.65M
June 30, 2021 147.10M
March 31, 2021 162.77M
December 31, 2020 95.77M
Date Value
September 30, 2020 105.31M
June 30, 2020 102.48M
March 31, 2020 111.98M
December 31, 2019 120.02M
September 30, 2019 134.74M
June 30, 2019 148.80M
March 31, 2019 163.92M
December 31, 2018 173.18M
September 30, 2018 184.25M
June 30, 2018 187.05M
March 31, 2018 138.13M
December 31, 2017 143.28M
September 30, 2017 -42.59M
June 30, 2017 -37.38M
December 31, 2016 -27.16M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

72.91M
Minimum
Sep 2024
162.77M
Maximum
Mar 2021
111.32M
Average
106.43M
Median

Shareholders Equity (Quarterly) Benchmarks

Affimed NV 19.21M
BioNTech SE 21.35B
Immatics NV 427.24M
CureVac NV 809.41M
ATAI Life Sciences NV 145.72M

Shareholders Equity (Quarterly) Related Metrics